A new study would look into how companies in the prescription drug supply chain get paid.
This bill would require the Government Accountability Office (GAO) to study how companies in the prescription drug supply chain get paid. The study would focus on payments linked to a drug's price. This research aims to show these payment structures and could help lawmakers address drug costs.
Currently, there isn't a detailed, public study from the government's watchdog about how companies in the prescription drug supply chain get paid based on a drug's price. This bill would change that by requiring the Government Accountability Office (GAO) to conduct such a study and report its findings to Congress.
S 3751 · 119th Congress · January 29, 2026 · AI Summary by gemini-2.5-flash · 10/10
Sign in to see your representatives' phone numbers
1 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.